Sep 27
Current report
8-K
Events of Aug 14
Financial results
FZMD · Fuse Medical, Inc.
Market Cap
$2.22M
Shares
73.90M
Volume · Nov 10
109.32K
Avg daily vol (9 sessions)
66.34K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.03
Open$0.03
Day$0.03–0.03
52W close$0.02–0.07
Avg vol 30d53K
Short int23K · 0.0% of shares · 999+d
Short vol84%
DataJan 2020–Nov 2026
Filing10-Q · Aug 14
Latest documents
2023
Aug 15
Current report
8-K
Events of Aug 14
Financial results
Aug 14
Quarterly report
10-Q
FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $5M
▲ 7.0%
Net income $307.59K
Jun 26
Current report
8-K
Events of Jun 23
Shareholder vote results
May 15
Quarterly report
10-Q
FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $3.98M
▼ 12.5%
Net loss $228.36K
Diluted EPS $0.00
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$18.40M
Trailing 12 months
Net income (TTM)
$3.98M
Trailing 12 months
Revenue growth YoY
+7.0%
Year over year
Operating margin
-0.7%
Trailing 12 months
P / E (TTM)
0.6
Trailing earnings · reciprocal yield 179.4%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+10.7%
Year over year · more shares
Price change (1Y)
-50.0%
Trailing year
Short interest
0.0%
Latest settlement · 999+ days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.72
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−70%
below
Price vs 50-day avg
−19%
below
RSI (14)
51
neutral
MACD trend
Positive
52-week position
20%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+50%
trailing
6-month return
−82%
trailing
YTD return
+50%
this year
Relative strength
−84%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.03% of shares out · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
44
elevated · 0–100
Fundamentals
Revenue growth
−0%
Y/Y
Gross margin
44%
contracting
EPS growth
+300%
Y/Y
Free cash flow
$14.0K
Quant / Vol
risk profile
Volatility
693%
annualized · 1-yr
Max drawdown
−96%
past year
ATR
21.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−70%
Bearish
Price vs 50-day avg
−19%
Bearish
RSI (14)
51
Neutral
MACD trend
Positive
Bullish
52-week position
20%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.03% of shares out · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 20%
Range high $0
vs 200-day avg -70%
vs 50-day avg -19%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FZMD
this stock
Fuse Medical, Inc.
|
$2.22M | +50.0% | -0.2% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$185.75B | -14.4% | +5.7% | 40.0 | 1.1% |
|
MDT
Medtronic plc
|
$129.18B | +5.1% | +8.4% | 24.9 | 1.8% |
|
SYK
Stryker Corp
|
$118.92B | -11.1% | +11.2% | 33.3 | 1.7% |
|
BSX
Boston Scientific Corp
|
$64.07B | -53.6% | +12.5% | 18.7 | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FZMD | +3.5% | +50.0% | -82.4% | +20.0% | +50.0% |
| SPY | -0.6% | -3.6% | +1.2% | -0.8% | +10.0% |
| vs SPY | +4.0% | +53.6% | -83.5% | +20.8% | +40.0% |